Insulet (PODD) unveiled a global partnership with Calm, a consumer mental health firm, to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals.
Financial details of the deal were not disclosed in the company statement early Tuesday.
The integrated content collaboration between Calm and a MedTech company is built on Insulet's global research "showing the essential role emotional well-being plays in diabetes management," it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments